Trial · NCT00095576
Adverse events102
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 102
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Diarrhoea | Gastrointestinal disorders | Trivalent MRKAd5 HIV-1 Gag/Pol/Nef | 156 | 1,484 | 195 |
| other | Diarrhoea | Gastrointestinal disorders | Placebo | 148 | 1,495 | 182 |
| other | Nausea | Gastrointestinal disorders | Trivalent MRKAd5 HIV-1 Gag/Pol/Nef | 94 | 1,484 | 114 |
| other | Nausea | Gastrointestinal disorders | Placebo | 75 | 1,495 | 87 |
| other | Fatigue | General disorders | Trivalent MRKAd5 HIV-1 Gag/Pol/Nef | 170 | 1,484 | 218 |
| other | Fatigue | General disorders | Placebo | 120 | 1,495 | 149 |
| other | Fever | General disorders | Trivalent MRKAd5 HIV-1 Gag/Pol/Nef | 376 | 1,484 | 631 |
| other | Fever | General disorders | Placebo | 309 | 1,495 | 548 |
| other | General body pain | General disorders | Trivalent MRKAd5 HIV-1 Gag/Pol/Nef | 76 | 1,484 | 98 |
| other | General body pain | General disorders | Placebo | 23 | 1,495 | 26 |
| other | Injection site erythema | General disorders | Trivalent MRKAd5 HIV-1 Gag/Pol/Nef | 317 | 1,484 | 448 |
| other | Injection site erythema | General disorders | Placebo | 143 | 1,495 | 197 |
| other | Injection site pain | General disorders | Trivalent MRKAd5 HIV-1 Gag/Pol/Nef | 961 | 1,484 | 1,862 |
| other | Injection site pain | General disorders | Placebo | 475 | 1,495 | 702 |
| other | Injection site swelling | General disorders | Trivalent MRKAd5 HIV-1 Gag/Pol/Nef | 337 | 1,484 | 511 |
| other | Injection site swelling | General disorders | Placebo | 115 | 1,495 | 149 |
| other | Injection site tenderness | General disorders | Trivalent MRKAd5 HIV-1 Gag/Pol/Nef | 271 | 1,484 | 374 |
| other | Injection site tenderness | General disorders | Placebo | 81 | 1,495 | 92 |
| other | Headache | Nervous system disorders | Trivalent MRKAd5 HIV-1 Gag/Pol/Nef | 461 | 1,484 | 734 |
| other | Headache | Nervous system disorders | Placebo | 394 | 1,495 | 631 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00095576/events